About Menarini Group
Menarini Group is a company based in Florence (Italy). It operates as a Direct-to-Consumer (D2C), and Professional Services. Menarini Group has completed 3 acquisitions, including Orbactiv, Silicon Biosystems and Stemline Therapeutics. Menarini Group offers products and services including Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine. Menarini Group operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Florence, Italy
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name A. Menarini Industrie Farmaceutiche Riunite Srl
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Orbactiv
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Menarini Group
Menarini Group offers a comprehensive portfolio of products and services, including Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medicines are developed for various therapeutic areas.
Products are offered for everyday health needs.
Therapies are provided for cancer patient care.
Solutions are created for professional diagnostic needs.
Products are designed for skin and aesthetics.
Unlock access to complete
Unlock access to complete
Funding Insights of Menarini Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Menarini Group
Menarini Group has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Orbactiv, Silicon Biosystems and Stemline Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of a single-dose antibiotic for bacterial skin infections. This antibiotic offers an alternative treatment for acute bacterial skin and skin structure infections caused by specific gram-positive microorganisms. It provides a single-dose option compared to multiple-dose regimens, and the company offers support programs for insurance verification, billing, and patient assistance. The product has three mechanisms of action and is indicated for adult patients. Important safety information includes potential interactions with anticoagulants and the need for monitoring of certain coagulation tests. Adverse reactions are documented in the full prescribing information.
|
2014 | ||||
|
Novel oncology therapeutics targeting cancer stem cells are developed.
|
2003 | ||||
|
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Menarini Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Menarini Group Comparisons
Competitors of Menarini Group
Menarini Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Menarini Group
Where is Menarini Group located?
Menarini Group is headquartered in Florence, Italy.
What does Menarini Group do?
Menarini Group is involved in the development and distribution of pharmaceutical products across various therapeutic areas, including oncology, cardiometabolic, and respiratory health. The company is also active in consumer healthcare, diagnostics, and dermatology. Research and innovation are prioritized to address serious health conditions. With a global presence, strategic partnerships are established to enhance product reach and impact. Sustainability and social responsibility are integrated into operations to support communities and environmental initiatives.
Who are the top competitors of Menarini Group?
Menarini Group's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Menarini Group offer?
Menarini Group offers Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine.
How many acquisitions has Menarini Group made?
Menarini Group has made 3 acquisitions, including Orbactiv, Silicon Biosystems, and Stemline Therapeutics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.